Literature DB >> 11254102

Cloning and analysis of the mouse follistatin promoter.

E de Groot1, J Veltmaat, A Caricasole, L Defize, A van den Eijnden-van Raaij.   

Abstract

Follistatin is a secreted protein, which functions as an antagonist of different members of the TGF-beta superfamily, including activin and bone morphogenetic proteins. Expression of follistatin is tightly regulated during mouse development both spatially and temporally. In order to study the regulation of follistatin expression in the mouse embryo we have cloned and analyzed part of the 5' flanking region of the murine follistatin gene. Primer extension and RNase protection assays demonstrate that the murine follistatin promoter region has at least three distinct transcription initiation sites, which are each preceded by a TATA box. All of the transcription initiation sites are located within the first 500 bp upstream of the translational start site. Sequence analysis of this 500 bp region revealed several consensus binding sites for transcription factors including AP-1, Brachyury-T, CREB, Sp1, AP-2 and Tcf. To test whether the 5' region displays promoter activity, we transfected various 5' flanking region deletion constructs into F9 embryonal carcinoma (EC) cells and into P19 EC cells. In these two cell lines a region of only 262 bp upstream of the translation start site could drivereporter expression in a manner that reflects endogenous mRNA expression.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11254102     DOI: 10.1023/a:1007159031000

Source DB:  PubMed          Journal:  Mol Biol Rep        ISSN: 0301-4851            Impact factor:   2.316


  39 in total

1.  Activin-binding protein from rat ovary is follistatin.

Authors:  T Nakamura; K Takio; Y Eto; H Shibai; K Titani; H Sugino
Journal:  Science       Date:  1990-02-16       Impact factor: 47.728

2.  The dorsalizing and neural inducing gene follistatin is an antagonist of BMP-4.

Authors:  A Fainsod; K Deissler; R Yelin; K Marom; M Epstein; G Pillemer; H Steinbeisser; M Blum
Journal:  Mech Dev       Date:  1997-04       Impact factor: 1.882

3.  A homodimer of the beta-subunits of inhibin A stimulates the secretion of pituitary follicle stimulating hormone.

Authors:  N Ling; S Y Ying; N Ueno; S Shimasaki; F Esch; M Hotta; R Guillemin
Journal:  Biochem Biophys Res Commun       Date:  1986-08-14       Impact factor: 3.575

4.  Human growth-differentiation factor 3 (hGDF3): developmental regulation in human teratocarcinoma cell lines and expression in primary testicular germ cell tumours.

Authors:  A A Caricasole; R H van Schaik; L M Zeinstra; C D Wierikx; R J van Gurp; M van den Pol; L H Looijenga; J W Oosterhuis; M F Pera; A Ward; D de Bruijn; P Kramer; F H de Jong; A J van den Eijnden-van Raaij
Journal:  Oncogene       Date:  1998-01-08       Impact factor: 9.867

5.  Differential expression of jun and fos genes during differentiation of mouse P19 embryonal carcinoma cells.

Authors:  R P de Groot; J Schoorlemmer; S T van Genesen; W Kruijer
Journal:  Nucleic Acids Res       Date:  1990-06-11       Impact factor: 16.971

6.  MatInd and MatInspector: new fast and versatile tools for detection of consensus matches in nucleotide sequence data.

Authors:  K Quandt; K Frech; H Karas; E Wingender; T Werner
Journal:  Nucleic Acids Res       Date:  1995-12-11       Impact factor: 16.971

7.  Promoter architecture, cofactors, and orphan receptors contribute to cell-specific activation of the retinoic acid receptor beta2 promoter.

Authors:  G E Folkers; B van der Burg; P T van der Saag
Journal:  J Biol Chem       Date:  1998-11-27       Impact factor: 5.157

8.  Differential expression of inhibin subunits and follistatin, but not of activin receptor type II, during early murine embryonic development.

Authors:  A J van den Eijnden-van Raaij; A Feijen; K A Lawson; C L Mummery
Journal:  Dev Biol       Date:  1992-12       Impact factor: 3.582

9.  Primary structure of the human follistatin precursor and its genomic organization.

Authors:  S Shimasaki; M Koga; F Esch; K Cooksey; M Mercado; A Koba; N Ueno; S Y Ying; N Ling; R Guillemin
Journal:  Proc Natl Acad Sci U S A       Date:  1988-06       Impact factor: 11.205

10.  Control of digit formation by activin signalling.

Authors:  R Merino; D Macias; Y Gañan; J Rodriguez-Leon; A N Economides; C Rodriguez-Esteban; J C Izpisua-Belmonte; J M Hurle
Journal:  Development       Date:  1999-05       Impact factor: 6.868

View more
  6 in total

1.  The Local Control of the Pituitary by Activin Signaling and Modulation.

Authors:  Louise M Bilezikjian; Wylie W Vale
Journal:  Open Neuroendocrinol J       Date:  2011-01-01

Review 2.  Cell-type specific modulation of pituitary cells by activin, inhibin and follistatin.

Authors:  Louise M Bilezikjian; Nicholas J Justice; Alissa N Blackler; Ezra Wiater; Wylie W Vale
Journal:  Mol Cell Endocrinol       Date:  2012-02-04       Impact factor: 4.102

Review 3.  Building pathways for ovary organogenesis in the mouse embryo.

Authors:  Chia-Feng Liu; Chang Liu; Humphrey H-C Yao
Journal:  Curr Top Dev Biol       Date:  2010       Impact factor: 4.897

4.  WNT4/beta-catenin pathway maintains female germ cell survival by inhibiting activin betaB in the mouse fetal ovary.

Authors:  Chia-Feng Liu; Keith Parker; Humphrey H-C Yao
Journal:  PLoS One       Date:  2010-04-29       Impact factor: 3.240

5.  Wnt/β-catenin controls follistatin signalling to regulate satellite cell myogenic potential.

Authors:  Andrew E Jones; Feodor D Price; Fabien Le Grand; Vahab D Soleimani; Sarah A Dick; Lynn A Megeney; Michael A Rudnicki
Journal:  Skelet Muscle       Date:  2015-04-28       Impact factor: 4.912

6.  Caveolin-1 regulation of Sp1 controls production of the antifibrotic protein follistatin in kidney mesangial cells.

Authors:  Neel Mehta; Dan Zhang; Renzhong Li; Tony Wang; Agata Gava; Pavithra Parthasarathy; Bo Gao; Joan C Krepinsky
Journal:  Cell Commun Signal       Date:  2019-04-17       Impact factor: 5.712

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.